Wall Street Journal. Europe 2007 Avery Johnson - Abstracts
| Wall Street Journal. Europe 2007 Avery Johnson | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Lilly settles 18,000 Zyprexa claims, but more loom.(Eli Lilly & Co.) | Business, international | Avery Johnson | |||
| New generation of cardiac stents awaits FDA approval: questions about safety could slow agency's review; addressing clotting issues. | Business, international | Avery Johnson | |||
| Pfizer overhaul faces timing dilemma.(pharmaceuticals)(United States)(includes Stock Quote and "Daily Share Price" statistical table)(Company overview)(Financial report) | Business, international | Avery Johnson | |||
| Pfizer's strategy takes shape; Europe sales team may be cut deeply; reorganizing R&D. | Business, international | Joann S. Lublin, Avery Johnson | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.